• ATRX-Deficient Glioma Vulnerability to Selective PDGFR Inhib

  2026-06-09

  This article examines recent findings that ATRX-deficient high-grade glioma cells are markedly more sensitive to receptor tyrosine kinase and PDGFR inhibitors, offering a potential precision strategy for targeting these aggressive tumors. The study underscores the importance of ATRX mutational status in interpreting therapeutic responses and designing future glioblastoma trials.

• Fumagillin: Applied Protocols for Methionine Aminopeptidase-

  2026-06-09

  Fumagillin offers robust, flexible inhibition of methionine aminopeptidase-2 for both angiogenesis and antiparasitic research. This guide details practical workflows, optimization strategies, and actionable troubleshooting tips to maximize reproducibility across cancer and disease models.

• iRGD-Modified RBC Membranes Enhance Photodynamic Therapy in

  2026-06-08

  This study introduces an iRGD-functionalized red blood cell membrane nanocarrier that significantly improves photodynamic therapy (PDT) efficacy in neuroblastoma models. Enhanced tumor targeting, increased drug encapsulation, and markedly improved antitumor outcomes highlight a promising approach for precision oncology.

• Technical Guide: Hoechst 33342/PI Double Staining Kit in Cel

  2026-06-08

  The Hoechst 33342/PI Double Staining Kit enables rapid, fluorescence-based discrimination of viable, apoptotic, and necrotic cells through simultaneous nuclear and membrane integrity assessment. It is suitable for basic research workflows involving chromatin condensation detection and membrane permeability assays, but is not intended for diagnostic or clinical use.

• ARCA Cy5 EGFP mRNA (5-moUTP) for High-Fidelity mRNA Delivery

  2026-06-07

  ARCA Cy5 EGFP mRNA (5-moUTP) streamlines direct monitoring of mRNA uptake and translation in mammalian cells with dual fluorescence and immune-silent design. Its robust 5-methoxyuridine modification and ARCA capping enable precise, reproducible assays for mRNA delivery optimization and troubleshooting.

• Human iPSC-Derived Sensory Neurons Enable HSV-1 Latency Mode

  2026-06-06

  This study introduces a robust and scalable protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons, enabling direct modeling of herpes simplex virus 1 (HSV-1) latency and reactivation in a human neuronal context. The platform addresses a critical need for species-relevant models to investigate the molecular mechanisms underlying HSV-1 latency and to guide therapeutic innovation.

• Pharmacogenomics of Chloroquine/Hydroxychloroquine: Systemat

  2026-06-05

  This systematic review synthesizes current pharmacogenomic evidence on chloroquine and hydroxychloroquine, highlighting how genetic variants in CYP2C8, CYP3A4/5, and CYP2D6 impact drug metabolism, safety, and efficacy. The findings underscore the need for genotype-informed therapy and provide a foundation for precision medicine approaches in diverse patient populations.

• Ginsenoside Rg1 Restores Neuroimmune Integrity After Anesthe

  2026-06-05

  The reference study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, reverses neuroimmune disruptions caused by prolonged isoflurane anesthesia in mice. The findings identify regulatory T cells as essential mediators of Rg1’s neuroprotective effects, offering mechanistic insight for post-anesthesia cognitive disorder research.

• RRP Extracts Restore Hepatic Lipid Metabolism in Ischemia-Re

  2026-06-04

  The referenced study demonstrates that Radix Rehmanniae Praeparata (RRP) extracts alleviate hepatic ischemia-reperfusion injury (HIRI) in mice by targeting key lipid metabolic pathways. Through AMPK activation, SREBP2 inhibition, and LXRα-mediated cholesterol efflux, RRP offers mechanistic insights for therapeutic strategies against postoperative liver complications.

• Betaine hydrochloride (SKU N1700): Reliable Assay Optimizati

  2026-06-04

  This article addresses persistent challenges in cell-based and enzyme assays, outlining how Betaine hydrochloride (SKU N1700) from APExBIO delivers reproducibility and workflow security through high purity and validated analytical controls. Scenario-driven Q&A blocks offer evidence-based guidance for experimental design, optimization, and vendor selection, making this article a practical resource for biomedical researchers seeking robust assay reagents.

• Dirigent Proteins Redirect Terpenoid Defense in Cotton Plant

  2026-06-03

  This study uncovers how two paralogous dirigent proteins in cotton act as gatekeepers, redirecting extracellular terpenoid metabolism to enhance defense against pests and pathogens. By elucidating the noncanonical synergy between dirigent proteins and aldo-keto reductases in producing potent phytoalexins, the research advances our understanding of spatially controlled plant defense mechanisms.

• LARP1–Ribosome Complexes: Structural Insights into TOP mRNA

  2026-06-03

  This study uncovers how LARP1 directly binds non-translating ribosomal subunits and TOP mRNAs, revealing a previously uncharacterized LARP1 domain that occludes the mRNA channel of the 40S subunit. Contrary to established models, ribosome binding by LARP1 is not required for TOP mRNA repression or stabilization, challenging existing assumptions and refining our understanding of translational regulation.

• Natural TaASN-B2 Deletion Lowers Asparagine in Wheat Grain

  2026-06-02

  Oddy et al. (2021) identified a natural deletion of the TaASN-B2 gene in wheat that leads to reduced free asparagine levels in the grain, offering a potential route to lower acrylamide formation in processed wheat foods. This genetic insight provides breeders a direct target for developing wheat varieties with improved food safety profiles.

• A-1210477: Advancing Functional MCL-1 Dependency Analysis in

  2026-06-02

  Discover how MCL-1 inhibitor A-1210477 offers unparalleled specificity for dissecting apoptosis regulation in cancer cells. This article explores deep functional insights—from molecular mechanism to practical protocol optimization—setting a new standard for MCL-1–targeted cancer research.

• FASN Inhibition Sensitizes Pancreatic Cancer to BH3 Mimetics

  2026-06-01

  The referenced study demonstrates that inhibiting fatty acid synthase (FASN) can dramatically sensitize pancreatic ductal adenocarcinoma (PDAC) cells to mitochondrial apoptosis triggered by BH3 mimetic drugs, including ABT-263 (Navitoclax). These findings provide a mechanistic rationale for combining metabolic and apoptotic pathway targeting in the fight against chemoresistant PDAC.

15706 records 1/1048 page Next 12345 下5页 Last page